Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology
Anthony L. Gotter, Andrea L. Webber, Paul J. Coleman, et al.
Pharmacological Reviews (2012) Vol. 64, Iss. 3, pp. 389-420
Closed Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
S P H Alexander, Helen E. Benson, Elena Faccenda, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 8, pp. 1459-1581
Open Access | Times Cited: 552
Sleep and pain: recent insights, mechanisms, and future directions in the investigation of this relationship
Alberto Herrero Babiloni, Béatrice P. De Koninck, Gabrielle Beetz, et al.
Journal of Neural Transmission (2019) Vol. 127, Iss. 4, pp. 647-660
Closed Access | Times Cited: 159
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Discovery and development of orexin receptor antagonists as therapeutics for insomnia
Christopher J. Winrow, John J. Renger
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 283-293
Open Access | Times Cited: 144
Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders
Tian‐Rui Xu, Yang Yang, Richard J. Ward, et al.
Cellular Signalling (2013) Vol. 25, Iss. 12, pp. 2413-2423
Closed Access | Times Cited: 142
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 113
Temperament and arousal systems: A new synthesis of differential psychology and functional neurochemistry
Ирина Трофимова, Trevor W. Robbins
Neuroscience & Biobehavioral Reviews (2016) Vol. 64, pp. 382-402
Open Access | Times Cited: 110
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Daniël Hoyer, Laura H. Jacobson
Neuropeptides (2013) Vol. 47, Iss. 6, pp. 477-488
Closed Access | Times Cited: 107
Orexins and stress
Laura A. Grafe, Seema Bhatnagar
Frontiers in Neuroendocrinology (2018) Vol. 51, pp. 132-145
Open Access | Times Cited: 106
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Orexin receptors as therapeutic drug targets
Anthony L. Gotter, Anthony J. Roecker, Richard Hargreaves, et al.
Progress in brain research (2012), pp. 163-188
Closed Access | Times Cited: 95
Orexin/hypocretin system and autonomic control
Daniela Grimaldi, Alessandro Silvani, Eduardo E. Benarroch, et al.
Neurology (2013) Vol. 82, Iss. 3, pp. 271-278
Closed Access | Times Cited: 89
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
Anthony L. Gotter, Christopher J. Winrow, Joseph Brunner, et al.
BMC Neuroscience (2013) Vol. 14, Iss. 1
Open Access | Times Cited: 88
Discovery and Characterization of ACT‐335827, an Orally Available, Brain Penetrant Orexin Receptor Type 1 Selective Antagonist
Michel A. Steiner, John Gatfield, Catherine Brisbare‐Roch, et al.
ChemMedChem (2013) Vol. 8, Iss. 6, pp. 898-903
Closed Access | Times Cited: 87
Evidence for orexinergic mechanisms in migraine
Jan Hoffmann, Weera Supronsinchai, Simon Akerman, et al.
Neurobiology of Disease (2014) Vol. 74, pp. 137-143
Closed Access | Times Cited: 83
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
Selective orexin receptor antagonists
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73
Structure and Function of Peptide-Binding G Protein-Coupled Receptors
Fan Wu, Gaojie Song, Chris de Graaf, et al.
Journal of Molecular Biology (2017) Vol. 429, Iss. 17, pp. 2726-2745
Closed Access | Times Cited: 70
The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior
Alessandra Matzeu, Eva R. Zamora-Martinez, Rémi Martin-Fardon
Frontiers in Behavioral Neuroscience (2014) Vol. 8
Open Access | Times Cited: 69
The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice
Marcelo F. Lopez, David E. Moorman, Gary Aston‐Jones, et al.
Brain Research (2016) Vol. 1636, pp. 74-80
Open Access | Times Cited: 66
Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems
Gary B. Kaplan, Gabrielle A. Lakis, Hryhoriy Zhoba
Brain Research Bulletin (2022) Vol. 186, pp. 106-122
Closed Access | Times Cited: 32
The Mechanism of the Gut-Brain Axis in Regulating Food Intake
Shouren Li, Mengqi Liu, Shixi Cao, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3728-3728
Open Access | Times Cited: 18
Emerging and upcoming therapies in insomnia
W.-H. Kim, Ho-Sook Kim
Translational and Clinical Pharmacology (2024) Vol. 32, Iss. 1, pp. 1-1
Open Access | Times Cited: 6
Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism
Christine Dugovic, Jonathan Shelton, Sujin Yun, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top